Latest Stem cell controversy Stories
DALLAS, August 29, 2014 /PRNewswire/ -- Launched June 2014, the "Stem Cell Research Products - Opportunities, Tools, and Technologies" market intelligence report supplies
Scientists in the University of Connecticut’s Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease.
DALLAS, April 23, 2014 /PRNewswire/ -- According to the new research report "Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications
A strategic report from the European Science Foundation examines the key scientific questions for human stem cell research in the context of the rapidly emerging field of regenerative medicine.
RnRMarketResearch.com adds latest report on “Opportunities in Human Embryonic Stem Cell (hESC) Products – Trends and Forecasts to 2017” to its store. Dallas,
Centagen has developed a breakthrough stem cell therapy that rejuvenates a patient's own adult stem cells.
Stem cells are a valuable resource for medical and biological research, but are difficult to study due to ethical and societal barriers.
- totally perplexed and mixed up.